Abstract
Rapid assessment and intervention of suicide risk are common and challenging in psychiatric emergency departments (PED). It is unclear whether distinct pathophysiological processes exist among depressive patients with suicidality. This study examined the network structures of biomarkers on Hypothalamic-Pituitary-Adrenal (HPA) axis, such as Adrenocorticotropic hormone (ACTH) and Corticosterone (Cort), as well as suicidality and depressive symptoms in mood disorder patients in PED. Mood disorder patients in PED were assessed with the measurements of suicidality and depressive symptoms, respectively. A network analysis was performed to identify central symptoms and bridge symptoms of this network and their links to ACTH and Cort. Network stability was examined using the case-dropping procedure. The Network Comparison Test (NCT) was conducted to evaluate whether network characteristics differed by gender. A total of 1815 mood disorder patients were recruited. The prevalence of SI was 31.2% (95% CI: 28.15–34.21%), SP was 30.4% (95% CI: 27.39–33.41%), SA was 30.62% (95% CI: 27.61–33.64%) among psychiatric outpatients. The mean score of HAMD-24 was 13.87 ± 8.02. Network analysis revealed that ‘Somatic anxiety’ had the highest expected centrality, followed by ‘Hopelessness’ and ‘Suicide attempt’. ‘Corticosterone’ and ‘Retardation’ may be the main bridge symptoms between depressive symptoms and the suicidality community. The network model showed a high degree of stability. Gender did not significantly influence the network structure. The central symptoms and key bridge symptoms identified could be potential targets for interventions of the HPA axis, which is designed for regular screening of a range of suicidal activity. In the light of this, timely treatment should be provided for psychiatric emergency care.
Similar content being viewed by others
Introduction
Suicide is an important cause of death worldwide. Approximately 800,000 people per year die by suicide, accounting for about 1.5% of all deaths [1]. It is estimated that one in ten of them had been admitted to an emergency department within two months of their death [2]. Since the emergence of ideation, attempts and completed suicide are associated with many factors, such as the demographic, psychosocial, clinical and biological factors [3, 4]. In addition, as a promising setting for suicide prevention, the psychiatric emergency department (PED) needs to establish some appropriate biological markers for universal screening, risk assessment and follow-up care standards [5].
Hyperactivity of the Hypothalamic–Pituitary–Adrenal (HPA) axis is well documented among patients suffering from psychiatric disorders [6]. Previous studies provide evidence that the Hypothalamic–Pituitary–Adrenal (HPA) axis is hyperactivity in young adult mood disorder inpatients who manifesting suicidal behavior and ideation [7, 8]. Furthermore, the lowest plasma cortisol and corticotrophin responses were found in the patients who recently attempted suicide. Also, a previous study suggests that the usage of neuroendocrine testing of HPA axis functioning as a complementary tool in suicide prevention [9].
Depression is the most common psychiatric disorder in people who die by suicide [10] and, therefore, detection of individuals at risk of suicide, while clearly extremely important, can be difficult. Many previous studies indicated that there is a positive association between severity of depression and suicidality [11, 12] but the specific item association is poorly understood. A two-year prospective cohort study following 91 individuals with mood disorders has found higher suicidality to be more strongly correlated with depression and hopelessness with the scale of HAMD (Hamilton Rating Scale for Depression) [13]. Furthermore, a flow network analysis result shows that suicide ideation was seems to be related directly to loneliness, sadness, pessimism, feeling important to their family, self-hatred and self-blame [14].
Traditionally, previous studies found that the total score of the depression positively correlated with the HPA axis, but the item level of the association is not clear. In addition, comorbidity depression and suicidality rely on total scale scores to describe symptom severity in the present researches. Unfortunately, such approach may obscure meaningful connections between individual symptoms. Network analysis has been more and more widely applied in the field of psychology and psychiatry in recent years. Network analysis is a novel analytical technique used to gain insights into a biological system by predicting how multiple syndromes and biological indicators [15, 16]. Network analysis has been used to elucidate structural relationships in symptoms in dimensions such as emotional, behavioral, and cognitive symptoms to screen for the most influential symptoms in the disease [17,18,19]. The clinical features of depression and suicidality are closely related to neuroendocrine factors. Therefore, findings based on inpatients and community samples do not necessarily as applicable within stressful contexts of rapidly changing psychiatric emergency departments [20, 21]. To the best of our knowledge, no study has examined comorbid ACTH and Cort, suicidality, and depressive symptoms from the perspective of network analysis.
Using a network approach, this study investigated the inter-relationships between ACTH and Cort, suicidality, and depressive symptoms in a large representative sample of mood disorder patients. The main focus was upon identifying central symptoms and bridge symptoms within this network model. The biomarkers were evaluated for association with symptoms simultaneously, leading to greater insights into the pathophysiology of disease states.
We hypothesize that high levels of Cort may represent an increase in neurobiological activity which might contribute to suicidality by exacerbating the level of hopelessness in depression that might hinder the foresight and consideration of consequences. If this hypothesis is correct and clinicians have sufficient evidence to identify the key risk factors for suicide in individuals with depression is therefore essential if clinicians are to identify those most at risk and intervene appropriately, as there is good evidence that monitoring and active treatment in high-risk patients may result in reduced suicide rates [22].
Methods
Patients and study sites
There was a cross-sectional survey carried out between January 2021 and March 2022, in Department of Emergency in Beijing Anding Hospital, which is the only 24-hour emergency service for psychiatric hospitals in Beijing municipality and neighboring provinces in North China. To be eligible, all participants were: (1) outpatients receiving emergency maintenance treatment for a major psychiatric disorder; (2) provided written and informed consent; (3) patients diagnosed with mood disorders (F30–F39), according to the International Statistical Classification of Diseases and Related Health Problems-10th revision (ICD-10) diagnostic criteria established by two consultant psychiatrists with over 15 years clinical experience; (4) and presenting with depression symptoms (i.e., 24-items Hamilton Depression Rating Scale (HAMD-24) total score of ≥8 [23], understanding of the aims of the study and the contents of the clinical interview and willingness to provide informed consent. This study was approved by the ethical committees of the Beijing Anding Hospital.
Blood collection and assays of ACTH, Cort
Serum samples were collected from all patients between 7:30 AM and 8:30 AM. Controlling for age and gender, the levels of 8 (7.30–8.30) AM serum were assayed by ACTH and Cort (μg/dl) using chemiluminescence. The laboratory personnel were blind to all clinical information. Samples and data were processed following standard operating procedures with the appropriate approval of the Ethics and Scientific Committee of Capital Medical University.
Measurement
In this study, the current suicidal ideation, suicide plan and suicide attempts were assessed through a face-to-face interview, which was conducted by a trained attending psychiatrist within 12 hours after admission. Following previous studies (Li et al., 2017), SI was assessed with a standard question (“Have you thought that you would be better off dead currently?”) that included a binary response option (yes/no). SP were assessed with a standard question (“Have you made a plan for suicide currently?”) featuring a binary response option (yes/no). SA were evaluated with a standard question (“Have you attempted suicide currently?”), including a binary response option (yes/no). Depressive symptoms was assessed using the validated Chinese version of the 24-items Hamilton Depression Rating Scale (HAMD-24) [24]. The Scale had been validated in the Chinese population with a sensitivity of 0.87 and specificity of 0.92 [25]. Each item with a score between 0 and 4 of the HAMD-24. A total score of 8 or above was diagnosed as depression, with a higher score indicating more severe depressive symptoms [23]. Following previous studies [26], item HAMD3 (“Suicide ideation”) is redundant with the SI component of suicidality; therefore, it was not included in network analysis.
Statistical analyses
The network model of depression, suicidality and ACTH was computed using the R software [27]. We computed the polychoric correlations between all the items to investigate the edges of the network, and also estimated the Graphical Gaussian Model (GGM), with the graphic least absolute shrinkage and selection operator (LASSO) and Extended Bayesian Information Criterion (EBIC) model using the R package ‘graph’ [28].
The importance of each node in the network was examined by estimating centrality indices of the network structure with the R package ‘graph’ [29]. Specifically, the centrality index of expected influence (EI) was computed for each node in the network (i.e., the sum of the weights of the connections, in absolute value), because EI is the most stable and interpretable centrality index [28]. Additionally, previous studies [30, 31] on comorbid psychiatric syndromes found that ‘ACTH’ was commonly reported to link between different symptom communities as a key node. Therefore, the node-specific predictive betweenness of ‘ACTH’ (i.e., how often a node lies on the pathways between two other nodes, always with the ‘ACTH’ node as either of them across 1000 nonparametric bootstrap iterations) was estimated [32,33,34]. To identify particular symptoms that were directly associated with ACTH, the ‘flow’ function in the R package ‘qgraph’ was used [28].
In particular for the stress axis, factors such as gender and sex steroids regulate ACTH secretion strongly in animals, investigations in human subjects are both limited and discrepant [35,36,37]. Considering the moderating effects of gender, network models were compared between genders. Following previous studies [38, 39], the differences in network characteristics between male and female participants were compared using the R ‘NetworkComparisonTest’ package (Version 2.2.1) [40] with 1000 permutations. The difference in network structure (e.g., distributions of edge weights), global strength (e.g., total absolute connectivity among the symptoms), and each specific edge between subsamples (i.e., females vs. males) were also examined.
Missing data
To minimize the likelihood of any missing values, researchers in each participating hospital checked the completion of the relevant questionnaires prior to data submission, and reminded participants to complete the missing items at a voluntary basis. As network methodologies are currently incompatible with multiple imputed data sets, network analysis in this study was performed based on the dataset comprising participants who completed the HAMD-24.
Results
A total of 1815 patients were invited to participate in this study, of whom 898 met the study criteria and were included in analyses. The prevalence of SI was 31.2% (95% CI: 28.15–34.21%), SP was 30.4% (95% CI: 27.39–33.41%), SA was 30.62% (95% CI: 27.61–33.64%) among psychiatric outpatients. The mean score of HAMD-24 was 13.87 (Standard Deviation (SD):8.02). Data reating to demographics and the clinical characteristics of the study population are summarized in Table 1.
Network structure
Figure 1 presents the network structure of comorbid suicidality, depression symptoms, ACTH and Cort in participants with mood disorders. The network model showed that the connection HAMD4 (‘Insomnia-initial’) – HAMD5 (‘Insomnia-middle’) was the strongest positive edge in the depressive symptom, followed by HAMD10 (‘Psychiatric anxiety’) – HAMD11 (‘Somatic anxiety’), and HAMD18 (‘Diurnal variation’) – HAMD19 (‘Depersonalization and derealization’). In the suicidality community, SA (‘Suicide attempt’) - SP (‘Suicide plan’) were the strongest edge, followed by SA (‘Suicide attempt’) - SI (‘Suicidal ideation’).
In terms of EI, the node HAMD11 (‘Somatic anxiety’) had the highest EI centrality, followed by HAMD23 (‘Hopelessness’) and SA (‘Suicide attempt’) in the network (Fig. 1). In terms of bridge EI, Cort (‘Corticosterone’) was the most key bridge symptom linking the suicidality and depressive symptom, followed by ACTH (‘Adrenocorticotropic’) and SI (‘Suicidal ideation’) (Fig. 1). In addition, we found that Cort (‘Corticosterone’) had the strongest positive association with ACTH in the flow network model, followed by the HAMD13 (‘General somatic symptoms’) and HAMD9 (‘Agitation’) (Fig. 2).
For the network stability, the centrality of EI had an excellent level of stability (i.e., CS-coefficient = 0.75 (95% CI: 0.675-1)), which indicates that 75% of the sample could be dropped, and the structure of the network did not significantly change (Fig. 3). The bootstrap difference test shows that most comparisons between edge weights are statistically significant.
Node-specific predictive betweenness measure
Previous studies found that ‘ACTH’ was strongly associated with the development of depression symptoms and suicidality in both patients with mood disorders [31]. The bootstrapping procedure showed that the estimation of node-specific predictive betweenness (i.e., items that more often lie on the shortest pathways from ‘ACTH’ to other nodes) was considerably less precise than that of other features of the network. Figure 3 shows the node-specific predictive betweenness values for each node in the network. The white dots represent the node-specific predictive betweenness in the study sample, while the black lines represent the variability of the measure across 1000 nonparametric bootstrap iterations. Cort (‘Corticosterone’) had the highest node-specific predictive betweenness score, followed by HAMD8 (‘Retardation’). This finding suggests that ‘Corticosterone’ and ‘Retardation’ may be the main bridge symptoms between depressive symptom and the suicidality community (Fig. 4).
Network comparison tests by gender
The comparison of network models by gender did not find significant differences in network global strength (network strength: 11.37 in female participants; 11.40 male participants; M = 0.214, P = 0.571) and edge weights (S = 0.026, P = 0.969, Supplementary Fig. S1–S4).
Discussion
This study is the first study conducted in a PED in China to examine comorbidity between levels of ACTH, Cort and depression and suicidality symptoms using network analysis. In the observed network model, depressive symptoms (e.g., ‘somatic anxiety’ and ‘hopelessness’) and suicide attempt were more influential in the sample and Corticosterone acted as the most key bridge symptom linking the suicidality and depressive symptom, followed by ACTH and SI. Gender was not a significant influence for the network structure, and the network had a high degree of stability.
In this network, we found that the strongest edge in the whole network was between depressive symptoms HAMD4 ‘Insomnia-initial’ and HAMD5 ‘Insomnia-middle’. This diverges from results of a major depression population study exploring relations between depressive symptoms and quality of life wherein the edge HAMD1- HAMD2 (Depressive mood - Feeling of guilt) was strongest [41]. Specifically, our study was conducted in an emergency room setting, leading to more extensive difficulty falling asleep and staying asleep due to acute stress states [42]. Our findings are consistent with previous findings, indicating hopelessness was identified as one of the central depressive symptoms in patients brought to the emergency room due to suicidality attempt [43]. The pessimism that grows out of hopelessness may result from adverse life events, such as bereavement [44, 45], economic and social problems [46], and physical illnesses [47, 48]. Stressors, medical and psychiatric comorbidities may trigger the progression of hopelessness to SI and suicidal behavior. It’s a continuous process, that is, from active suicidal intent, to planning, and finally to suicidal behavior [49]. The severity and urgency of suicidality must be dealt with by an emergency psychiatric department rather than a general psychiatric clinic [50]. The network identified in this study also showed that the node HAMD11 ‘Somatic anxiety’ was another central symptom of depression and suicidality symptoms network model. Our findings also confirmed the previous findings that somatic anxiety of anxiety cluster was significantly associated with youth-reported SI [51,52,53]. It has been hypothesized that chronic exposure to somatic anxiety may lead to the consideration of suicide as a means of relieving symptoms [54] based on escape-based mentality theory. Consistent with this theory, individuals suffering symptoms of somatic anxiety are more likely to have suicidal thoughts and behaviors due to an escape-based mentality that give an idea of escape from the situation and reduce mental pain (Williams & Pollock, 2000).
The strong association between hopelessness and suicidality suggests an underlying neurobiology, manifested by an increased stress hormone response, which was in line with extant literature [55]. Furthermore, the epigenetic mechanisms had indicated that glucocorticoid receptor (GR) downregulation and increased sensitivity to GR are present in suicide attempters, resulting in decreased HPA axis activity during acute depressive states [31, 56]. The blunted stress hormone response was a trait of suicide risk. The patients with a history of suicide attempts belonged to a subgroup of individuals that exhibit a more attenuated HPA response [57]. As previously reported, low baseline cortisol levels in suicide attempters had been interpreted to be associated with prolonged chronic stress leading to the “ burnt-out “ of the most important HPA axis, resulting in a suicide attempt [58, 59]. The trophic effects of ACTH on the adrenal gland induced by emotional symptoms, and elevated cortisol in SI, were associated with chronic increases in ACTH and decreased negative feedback compared with SA.
In particular, ‘Cort’ acted as both an important central symptom and bridge symptom in the current network model. ‘Cort’ and ‘Retardation’ also had high node-specific predictive betweenness (i.e., more often lies on the shortest pathway from ACTH to other nodes). These results are consistent with previous research identifying that elevated corticotropin-releasing hormone (CRH) peptides in the cerebrospinal fluid were detected in suicidal patients [60], as well as increased CRH mRNA expression in the prefrontal cortex [61] which are associated with mental stress. Dysfunctions of the prefrontal cortex leads to dysregulation of emotional and cognitive responses, leading to strong and long-term negative emotional states and SI [62]. The activity of HPA axis can be signficantly affected by the diurnal variation. Salivary Crot levels over the day (between 8 AM and 10 PM) have been shown to correlate negatively with performance in hippocampus-related neuropsychological memory tasks and executive function [63]. It was reported that the different threshold for the Crot levels may offer a better identification of suicide in the dexamethasone suppression test (DST) in patients with mood disorders [64]. Other HPA axis measures, such as the cortisol awakening response (CAR) and diurnal cortisol slope, have also been associated with impaired cognition in depressive patients [65]. Cognitive responses change in mental stress environment often manifests as retardation, triggering suicidal behavior [66,67,68].
Identifying central symptoms and bridge symptoms within the suicidality and depressive symptom network model has possible clinical significance; targeting these symptoms may contribute to prevention among at-risk suicidality patients [69]. This network model highlighted the important role of control processes for possible targeted treatment for mood disorders patients in PED at high risk of suicide. The Safety Planning Intervention (SPI) is a promising intervention to target central symptoms and bridge symptoms including “somatic anxiety”, “hopelessness”, and “suicide attempt” via a prioritized list of coping skills and strategies and mitigate risk of suicide when evaluating and treating PED patients who are at increased risk for suicide [70, 71]. 6 months following discharge is a defined high-risk period for suicide, and follow-up SPI are recommended for patients with a history of suicide in the PED [72].
Strengths of this study included the relatively large sample size, use of standardized assessment tools, and application of advanced network analysis statistics designed to explore the structure of ACTH and suicide model in mood disorder patients which could identify the potential targets in treatments and preventions for mood disorder patients in psychiatric emergency with these problems. However, our study has several methodological limitations to consider: Firstly, causal relations between variables could not be determined due to the cross-sectional nature of the study. Future, longitudinal studies are warranted to explain the temporal causal relationships between ACTH and suicide in mood disorders patients. Secondly, suicide community in our study were assessed by self-report measures. Therefore, the possibility of recall bias could not be excluded. Thirdly, patients with clinically diagnosed mood disorders including bipolar and unipolar depression were included, thus the heterogeneity of study participants may contribute to estimation of network structure for the variables. Fourthly, other moderators such as age, education level, and other clinical information should be included in the network comparison analyses. In addition, in order to ensure the rhythm changes of HPA, blood samples have been collected in the morning. Lastly, a consecutive sample of patients from only one major PED in China was recruited, which limits the generalization of the findings to other psychiatric settings.
In conclusion, symptoms related to somatic anxiety and hopelessness were identified as those most critical within the depression-suicidality network model in terms of node and bridge centrality as well as their associations with ACTH and Cort among mood disorders patients in emergency department. As such, specific depressive symptoms as potential targets for intervention can warrant the physicians’ attention in the evaluation protocol. In light of this, timely treatment should be provided for those seeking emergency psychiatric help.
Data availability
The data of the investigation will be made publicly available if necessary.
References
Naghavi M. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016. Bmj. 2019;364:l94. https://doi.org/10.1136/bmj.l94.
Laliberte AZ, Roth B, Edwards B, Chen JI. Suicide screening and risk assessment in the emergency department: case review of a suicide attempt survivor. J Emerg Nurs. 2021;47:846–51. https://doi.org/10.1016/j.jen.2021.07.010.
Rajewska-Rager A, Sibilski P, Lepczyńska N. Risk factors for suicide among children and youths with bipolar spectrum and early bipolar disorder. Psychiatr Pol. 2015;49:477–88. https://doi.org/10.12740/pp/29415.
Barbalat G, Liu S. Socio-demographic development and burden of mental, substance use disorders, and self-harm: an ecological analysis using the Global Burden of Disease study 2019. Aust N. Z J Psychiatry. 2022;56:1617–27. https://doi.org/10.1177/00048674211066764.
Bird S, Lago L, Eagar K, Pai N. Suicide prevention: Emergency departments are crucial for surveillance of self-harm and suicide-related behaviours. Aust N. Z J Psychiatry. 2021;55:729–30. https://doi.org/10.1177/00048674211009600.
Bao A-M, Meynen G, Swaab D. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev. 2008;57:531–53.
Jokinen J, Nordström P. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J Affect Disord. 2009;116:117–20.
O’Connor DB, Green JA, Ferguson E, O’Carroll RE, O’Connor RC. Cortisol reactivity and suicidal behavior: Investigating the role of hypothalamic-pituitary-adrenal axis responses to stress in suicide attempters and ideators. Psychoneuroendocrinology. 2017;75:183–91.
Jokinen J, Nordström P. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients. Psychoneuroendocrinology. 2008;33:1387–93.
Hawton K, Casañas I, Comabella C, Haw C, Saunders K. Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord. 2013;147:17–28.
Cai H, Jin Y, Liu S, Zhang Q, Zhang L, Cheung T, et al. Prevalence of suicidal ideation and planning in patients with major depressive disorder: a meta-analysis of observation studies. J Affect Disord. 2021;293:148–58.
Garlow SJ, Rosenberg J, Moore JD, Haas AP, Koestner B, Hendin H, et al. Depression, desperation, and suicidal ideation in college students: results from the American Foundation for suicide prevention college screening project at Emory University. Depression anxiety. 2008;25:482–8.
Johnson SL, McMurrich SL, Yates M. Suicidality in bipolar I disorder. Suicide Life Threat Behav. 2005;35:681–9. https://doi.org/10.1521/suli.2005.35.6.681.
Gijzen MWM, Rasing SPA, Creemers DHM, Smit F, Engels RCME, De Beurs D. Suicide ideation as a symptom of adolescent depression. A network analysis. J Affect Disord. 2021;278:68–77.
Sharma A, Demissei BG, Tromp J, Hillege HL, Cleland JG, O'Connor CM, et al. A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure. Eur J Heart Fail. 2017;19:1310–20. https://doi.org/10.1002/ejhf.912.
Creixell P, Reimand J, Haider S, Wu G, Shibata T, Vazquez M, et al. Pathway and network analysis of cancer genomes. Nat Methods. 2015;12:615–21. https://doi.org/10.1038/nmeth.3440.
Marchetti I. Hopelessness: a network analysis. Cogn Ther Res. 2019;43:611–9. https://doi.org/10.1007/s10608-018-9981-y.
Nunez D, Ulloa JL, Guillaume S, Olie E, Alacreu-Crespo A, Courtet P. Suicidal ideation and affect lability in single and multiple suicidal attempters with major depressive disorder: an exploratory network analysis. J Affect Disord. 2020;272:371–9. https://doi.org/10.1016/j.jad.2020.04.004.
Beard C, Millner AJ, Forgeard MJC, Fried EI, Hsu KJ, Treadway MT, et al. Network analysis of depression and anxiety symptom relationships in a psychiatric sample. Psychol Med. 2016;46:3359–69. https://doi.org/10.1017/s0033291716002300.
Chang HB, Munroe S, Gray K, Porta G, Douaihy A, Marsland A, et al. The role of substance use, smoking, and inflammation in risk for suicidal behavior. J Affect Disord. 2019;243:33–41. https://doi.org/10.1016/j.jad.2018.09.005.
Cantarelli Mda G, Tramontina AC, Leite MC, Gonçalves CA. Potential neurochemical links between cholesterol and suicidal behavior. Psychiatry Res. 2014;220:745–51. https://doi.org/10.1016/j.psychres.2014.10.017.
Isometsä ET, Henriksson MM, Aro HM, Heikkinen ME, Kuoppasalmi KI, Lönnqvist JK. Suicide in major depression. Am J Psychiatry. 1994;151:530–6.
Addington D, Addington J, Atkinson M. A psychometric comparison of the calgary depression scale for schizophrenia and the hamilton depression rating scale. Schizophr Res. 1996;19:205–12. https://doi.org/10.1016/0920-9964(95)00070-4.
Jia L, Shang YY, Jiang SM, Xie Q, Huang YX, Xie DR, et al. Relationship between symptoms of pancreatic cancer-related depression and quality of life of patients. Zhonghua Yi Xue Za Zhi. 2009;89:1847–9.
Zheng Y, Zhao J, Phillips M, Liu J, Cai M, Sun S, et al. Validity and reliability of the Chinese hamilton depression rating scale. Br J Psychiatry. 1988;152:660–4. https://doi.org/10.1192/bjp.152.5.660.
Price M, Legrand AC, Brier ZM, Hébert-Dufresne L. The symptoms at the center: examining the comorbidity of posttraumatic stress disorder, generalized anxiety disorder, and depression with network analysis. J Psychiatr Res. 2019;109:52–58.
R Core Team. R: A language and environment for statistical computing. https://www.R-project.org/ (2020).
Epskamp S, Borsboom D, Fried EI. Estimating psychological networks and their accuracy: a tutorial paper. Behav Res Methods. 2018;50:195–212.
Epskamp S, Cramer AO, Waldorp LJ, Schmittmann VD, Borsboom D. qgraph: network visualizations of relationships in psychometric data. J Stat Softw. 2012;48:1–18.
Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, et al. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatry. 2005;57:336–42. https://doi.org/10.1016/j.biopsych.2004.11.017.
Hennings JM, Ising M, Uhr M, Holsboer F, Lucae S. Effects of weariness of life, suicide ideations and suicide attempt on HPA axis regulation in depression. Psychoneuroendocrinology. 2021;131:105286. https://doi.org/10.1016/j.psyneuen.2021.105286.
Barrat A, Barthelemy M, Pastor-Satorras R, Vespignani A. The architecture of complex weighted networks. Proc Natl Acad Sci. 2004;101:3747–52.
Newman ME. Analysis of weighted networks. Phys Rev E. 2004;70:056131.
Isvoranu A-M, Guloksuz S, Epskamp S, van Os J, Borsboom D. Toward incorporating genetic risk scores into symptom networks of psychosis. Psychological Med. 2020;50:636–43.
Liu J, Bisschop PH, Eggels L, Foppen E, Fliers E, Zhou J, et al. Intrahypothalamic estradiol modulates hypothalamus-pituitary-adrenal-axis activity in female rats. Endocrinology. 2012;153:3337–44. https://doi.org/10.1210/en.2011-2176.
Handa RJ, Sheng JA, Castellanos EA, Templeton HN, McGivern RF. Sex Differences in Acute Neuroendocrine Responses to Stressors in Rodents and Humans. Cold Spring Harb Perspect Biol. 2022;14:a039081. https://doi.org/10.1101/cshperspect.a039081.
Sharma A, Aoun P, Wigham J, Weist S, Veldhuis JD. Gender determines ACTH recovery from hypercortisolemia in healthy older humans. Metabolism. 2013;62:1819–29. https://doi.org/10.1016/j.metabol.2013.08.014.
Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors associated with mental health outcomes among health care workers exposed to Coronavirus Disease 2019. JAMA Netw Open. 2020;3:e203976. https://doi.org/10.1001/jamanetworkopen.2020.3976.
Zhang W, Wang K, Yin L, Zhao W, Xue Q, Peng M, et al. Mental health and psychosocial problems of medical health workers during the COVID-19 epidemic in China. Psychother Psychosom. 2020;89:242–50. https://doi.org/10.1159/000507639.
van Borkulo CD, et al. Comparing network structures on three aspects: a permutation test., https://doi.org/10.13140/RG.2.2.29455.38569 (2017).
Zhou, J, Zhou J, Feng L, Feng Y, Xiao L, Chen X, et al. The associations between depressive symptoms, functional impairment, and quality of life, in patients with major depression: undirected and Bayesian network analyses. Psychol Med. 1–13, https://doi.org/10.1017/s0033291722003385 (2022).
Blumenthal H, Taylor DJ, Cloutier RM, Baxley C, Lasslett H. The links between social anxiety disorder, insomnia symptoms, and alcohol use disorders: findings from a large sample of adolescents in the United States. Behav Ther. 2019;50:50–59. https://doi.org/10.1016/j.beth.2018.03.010.
Grover S, Sarkar S, Bhalla A, Chakrabarti S, Avasthi A. Demographic, clinical and psychological characteristics of patients with self-harm behaviours attending an emergency department of a tertiary care hospital. Asian J Psychiatr. 2016;20:3–10. https://doi.org/10.1016/j.ajp.2016.01.006.
Fried EI, Bockting C, Arjadi R, Borsboom D, Amshoff M, Cramer AOJ, et al. From loss to loneliness: the relationship between bereavement and depressive symptoms. J Abnorm Psychol. 2015;124:256–65. https://doi.org/10.1037/abn0000028.
Scocco P, Preti A, Totaro S, Corrigan PW, Castriotta C. Stigma, grief and depressive symptoms in help-seeking people bereaved through suicide. J Affect Disord. 2019;244:223–30. https://doi.org/10.1016/j.jad.2018.10.098.
Kalin NH. Anxiety, depression, and suicide in youth. Am J Psychiatry. 2021;178:275–9. https://doi.org/10.1176/appi.ajp.2020.21020186.
Yeh ST, Ng YY, Wu SC. Association of psychiatric and physical illnesses with suicide in older adults in Taiwan. J Affect Disord. 2020;264:425–9. https://doi.org/10.1016/j.jad.2019.11.070.
Khazem LR, Jahn DR, Cukrowicz KC, Anestis MD. Health conditions, physical disabilities, perceived burdensomeness, and depressive symptoms influence suicidal ideation. Death Stud. 2017;41:220–5. https://doi.org/10.1080/07481187.2016.1251509.
Bornheimer LA, Wojtalik JA, Li J, Cobia D, Smith MJ. Suicidal ideation in first-episode psychosis: considerations for depression, positive symptoms, clinical insight, and cognition. Schizophr Res. 2021;228:298–304. https://doi.org/10.1016/j.schres.2020.12.025.
Miller IW, Camargo CA, Arias SA, Sullivan AF, Allen MH, Goldstein AB, et al. Suicide prevention in an emergency department population: the ED-SAFE study. JAMA Psychiatry. 2017;74:563–70. https://doi.org/10.1001/jamapsychiatry.2017.0678.
Teismann T, Lukaschek K, Hiller TS, Breitbart J, Brettschneider C, Schumacher U, et al. Suicidal ideation in primary care patients suffering from panic disorder with or without agoraphobia. BMC Psychiatry. 2018;18:305. https://doi.org/10.1186/s12888-018-1894-5.
Capron DW, Allan NP, Ialongo NS, Leen-Feldner E, Schmidt NB. The depression distress amplification model in adolescents: a longitudinal examination of anxiety sensitivity cognitive concerns, depression and suicidal ideation. J Adolesc. 2015;41:17–24. https://doi.org/10.1016/j.adolescence.2015.02.001.
Crawford EA, Burke TA, Siegel D, Jager-Hyman S, Alloy LB, Kendall PC. Somatic symptoms of anxiety and suicide ideation among treatment-seeking youth with anxiety disorders. Suicide Life Threat Behav. 2019;49:811–25. https://doi.org/10.1111/sltb.12479.
Rodriguez KA, Kendall PC. Suicidal ideation in anxiety-disordered youth: identifying predictors of risk. J Clin Child Adolesc Psychol. 2014;43:51–62. https://doi.org/10.1080/15374416.2013.843463.
Mazer AK, Cleare AJ, Young AH, Juruena MF. Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures. Behav Brain Res. 2019;357-358:48–56. https://doi.org/10.1016/j.bbr.2018.04.015.
Melhem NM, Munroe S, Marsland A, Gray K, Brent D, Porta G, et al. Blunted HPA axis activity prior to suicide attempt and increased inflammation in attempters. Psychoneuroendocrinology. 2017;77:284–94. https://doi.org/10.1016/j.psyneuen.2017.01.001.
O’Connor DB, Gartland N, O’Connor RC. Stress, cortisol and suicide risk. Int Rev Neurobiol. 2020;152:101–30. https://doi.org/10.1016/bs.irn.2019.11.006.
Melhem NM, Porta G, Oquendo MA, Zelazny J, Keilp JG, Iyengar S, et al. Severity and variability of depression symptoms predicting suicide attempt in high-risk individuals. JAMA Psychiatry. 2019;76:603–13. https://doi.org/10.1001/jamapsychiatry.2018.4513.
Keilp JG, Stanley BH, Beers SR, Melhem NM, Burke AK, Cooper TB, et al. Further evidence of low baseline cortisol levels in suicide attempters. J Affect Disord. 2016;190:187–92. https://doi.org/10.1016/j.jad.2015.10.012.
Brunner J, Stalla GK, Stalla J, Uhr M, Grabner A, Wetter TC, et al. Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters. J Psychiatr Res. 2001;35:1–9. https://doi.org/10.1016/s0022-3956(01)00007-3.
Pandey GN, Rizavi HS, Bhaumik R, Ren X. Increased protein and mRNA expression of corticotropin-releasing factor (CRF), decreased CRF receptors and CRF binding protein in specific postmortem brain areas of teenage suicide subjects. Psychoneuroendocrinology. 2019;106:233–43. https://doi.org/10.1016/j.psyneuen.2019.04.015.
Price RB, Duman R. Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Mol Psychiatry. 2020;25:530–43. https://doi.org/10.1038/s41380-019-0615-x.
Hinkelmann K, Moritz S, Botzenhardt J, Riedesel K, Wiedemann K, Kellner M, et al. Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry. 2009;66:879–85. https://doi.org/10.1016/j.biopsych.2009.06.023.
Jokinen J, Nordström AL, Nordström P. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. J Affect Disord. 2008;106:145–52. https://doi.org/10.1016/j.jad.2007.06.008.
Salvat-Pujol N, Labad J, Urretavizcaya M, de Arriba-Arnau A, Segalas C, Real E, et al. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: the role of remission status. Psychoneuroendocrinology. 2017;76:38–48. https://doi.org/10.1016/j.psyneuen.2016.11.007.
Kern S, Oakes TR, Stone CK, McAuliff EM, Kirschbaum C, Davidson RJ. Glucose metabolic changes in the prefrontal cortex are associated with HPA axis response to a psychosocial stressor. Psychoneuroendocrinology. 2008;33:517–29. https://doi.org/10.1016/j.psyneuen.2008.01.010.
Ming Q, Zhong X, Zhang X, Pu W, Dong D, Jiang Y, et al. State-independent and dependent neural responses to psychosocial stress in current and remitted depression. Am J Psychiatry. 2017;174:971–9. https://doi.org/10.1176/appi.ajp.2017.16080974.
Jollant F, Lawrence NL, Olié E, Guillaume S, Courtet P. The suicidal mind and brain: a review of neuropsychological and neuroimaging studies. World J Biol Psychiatry. 2011;12:319–39. https://doi.org/10.3109/15622975.2011.556200.
Cai H, Li ZL, He F, Li SY, Zhao YJ, Zhang WY, et al. Suicide ideation and anhedonia among clinically stable adolescents with the recurrent depressive disorder during the COVID-19 pandemic: a network perspective. J Affect Disord. 2023;324:317–24. https://doi.org/10.1016/j.jad.2022.12.052.
Stanley B, Brown GK, Brenner LA, Galfalvy HC, Currier GW, Knox KL, et al. Comparison of the safety planning intervention with follow-up vs usual care of suicidal patients treated in the emergency department. JAMA Psychiatry. 2018;75:894–900. https://doi.org/10.1001/jamapsychiatry.2018.1776.
Boudreaux ED, Stanley B, Green KL, Galfalvy H, Brown GK. A randomized, controlled trial of the safety planning intervention: research design and methods. Contemp Clin Trials. 2021;103:106291. https://doi.org/10.1016/j.cct.2021.106291.
Olfson M, Marcus SC, Bridge JA. Focusing suicide prevention on periods of high risk. JAMA. 2014;311:1107–8. https://doi.org/10.1001/jama.2014.501.
Funding
The study was supported by the project initiated by the researchers in Beijing Anding Hospital (2022(30)).
Author information
Authors and Affiliations
Contributions
Conception and design: XJ, X-MX. Administrative support: XJ, YL, Y-FW. Provision of study materials or patients: G-YY, YL, TH, JL. Collection and assembly of data: Y-FW, YL, TH, JL. Data analysis and interpretation: Y-FW, X-MX, G-YY. Manuscript writing: all authors. Final approval of manuscript: all authors.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study involving human participants were reviewed and approved by Human Research and Ethics Committee of Beijing Anding Hospital, Capital Medical University. All the study procedures were carried out in accordance with relevant guidelines.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, YF., You, Gy., Han, T. et al. Network analysis of comorbid depression, suicidality and biomarkers on HPA axis among mood disorder patients to psychiatric emergency services. Transl Psychiatry 13, 203 (2023). https://doi.org/10.1038/s41398-023-02503-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41398-023-02503-5